Quarterly ResultAug 6, 2026, 04:17 PM
Azenta Q3 Net Loss $(173.8)M; Goodwill Impairment $149.1M
AI Summary
Azenta reported a net loss of $(173.8) million for the nine months ended June 30, 2026, significantly wider than the $(106.6) million loss in the prior year, primarily due to a $149.1 million goodwill and intangible assets impairment. For the third quarter, the company posted a net income of $2.5 million, a substantial improvement from a $(48.0) million loss year-over-year, largely benefiting from income from discontinued operations. The company completed the sale of its B Medical Systems business for $63.0 million on July 1, 2026.
Key Highlights
- Net loss for the nine months ended June 30, 2026, was $(173.8) million, compared to $(106.6) million in prior year.
- Goodwill and intangible assets impairment totaled $149.1 million for the nine months ended June 30, 2026.
- Q3 2026 net income was $2.5 million, a significant improvement from a $(48.0) million loss in Q3 2025.
- Total revenue for Q3 2026 increased 12.0% to $161.2 million, from $143.9 million in Q3 2025.
- Sale of B Medical Systems business completed on July 1, 2026, for $63.0 million.
- Net cash provided by operating activities for nine months decreased 48.8% to $35.8 million.
- Cash and cash equivalents decreased 32.2% to $189.7 million since September 30, 2025.
- Share repurchases amounted to $50.0 million for the nine months ended June 30, 2026.
Price Impact
More from AZTA